Guangdong Jiaying Pharmaceutical (002198.SZ) announced its interim report for the first half of 2024. During the reporting period, the total operating income was 0.18 billion yuan, a decrease of 30.00% compared to the same period last year. The net income attributable to shareholders of the listed company was 5.6677 million yuan, a decrease of 68.94% compared to the same period last year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.1626 million yuan, a decrease of 93.07% compared to the same period last year. The basic earnings per share is 0.0112 yuan.
嘉应制药(002198.SZ)：上半年净利润566.77万元，同比下降68.94%
Guangdong Jiaying Pharmaceutical (002198.SZ): the net income in the first half of the year was 5.6677 million yuan, a year-on-year decrease of 68.94%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.